文献速递慢阻肺

SIGLEC9基因多态性对慢阻肺表型及急性加重频率的影响

Influence of SIGLEC9 polymorphisms on COPD phenotypes including exacerbation frequency.
PubMed 文献 · Respirology · 2016-11-22

本研究探讨SIGLEC9基因多态性与慢阻肺急性加重频率及肺气肿严重程度的关系。在135名受试者中分析急性加重频率,在362名日本吸烟者(含244例慢阻肺患者)中分析气流受限与肺气肿,并在ECLIPSE白种人群队列中验证。结果发现rs2075803 G等位基因及GA单倍型与更高的急性加重频率和肺气肿程度相关,但未在ECLIPSE中重复;体外实验显示GA单倍型对应的Siglec-9变异体产生更多TNF-α。

要点

  • SIGLEC9 rs2075803 G等位基因与慢阻肺急性加重频率升高相关。
  • GA单倍型与肺气肿程度相关,但未在ECLIPSE白种人群中重复。
  • GA单倍型对应的Siglec-9变异体抑制炎症反应能力较弱。

核心结论

  • SIGLEC9 rs2075803 G/rs2258983 A单倍型可能为肺气肿发生的危险因素。

研究设计与样本

  • 研究纳入135名受试者分析急性加重频率,362名日本吸烟者(含244例慢阻肺患者)分析气流受限与肺气肿。
  • 在ECLIPSE白种人群中进行关联验证,并用体外实验分析编码SNP对Siglec-9功能的影响。

主要发现

  • rs2075803 G等位基因及GA单倍型与慢阻肺患者更高的急性加重频率相关。
  • rs2075803 G等位基因及GA单倍型与肺气肿程度相关。
  • 上述关联未在ECLIPSE研究中重复。
  • 表达GA单倍型对应Siglec-9变异体的髓系细胞系产生更多TNF-α。

临床怎么用

  • SIGLEC9 rs2075803 G/rs2258983 A单倍型可能有助于识别肺气肿发生风险较高的慢阻肺患者。

局限性

  • 主要关联结果未在ECLIPSE白种人群队列中重复。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: The exacerbation-prone phenotype of COPD is particularly important, as exacerbations lead to poor quality of life and disease progression. We previously found that COPD patients who lack Siglec-14, a myeloid cell protein that recognizes bacteria and triggers inflammatory responses, are less prone to exacerbation. We hypothesized that the variations in other SIGLEC genes could also influence COPD exacerbation frequency, and investigated the association between SIGLEC9 polymorphisms and the exacerbation-prone phenotype of COPD. METHODS: We examined whether SIGLEC9 polymorphisms affect the frequency of COPD exacerbation in 135 subjects within our study population, and also analysed the correlation between the genotypes and the severity of airflow obstruction and emphysema in 362 Japanese smokers including 244 COPD patients. The association between these single nucleotide polymorphisms (SNPs) and COPD phenotypes were also assessed in a Caucasian population of ECLIPSE study. The effects of these coding SNPs (cSNPs) on Siglec-9 protein functions were analysed using in vitro assays. RESULTS: The G allele of rs2075803 and rs2075803 G/rs2258983 A(GA) haplotype in SIGLEC9 was associated with higher frequency of exacerbations and the extent of emphysema in COPD. These results did not replicate in the ECLIPSE study. A myeloid cell line expressing the Siglec-9 variant corresponding to GA haplotype produced more TNF-α than the one expressing the variant corresponding to the other major haplotype. CONCLUSION: The SIGLEC9 rs2075803 G/rs2258983 A haplotype, which corresponds to a Siglec-9 variant that is less effective at suppressing inflammatory response, may be a risk factor for the development of emphysema.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Ishii T, Angata T, Wan ES, et al. Influence of SIGLEC9 polymorphisms on COPD phenotypes including exacerbation frequency. Respirology. 2016. PMID: 27878892. doi:10.1111/resp.12952

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。